Browsing: Longevity

Commercial astronauts showed rapid DNA methylation changes that mostly reversed on return – a stress test for immunity and resilience.…

Neurotech company targets non-surgical methods for connecting humans with ‘advanced AI’ and other technologies.   Sam Altman’s latest venture, brain-computer…

New research suggests Junevity’s siRNA approach could reverse age-related cellular decline without triggering dedifferentiation or cancer-related pathways. A new paper…

Biosplice submits NDA for lorecivivint, a potential first-of-its-kind therapy that aims to slow knee osteoarthritis itself. Osteoarthritis shapes how millions…

Loyal’s lead drug for senior dogs moves closer to market, marking a rare regulatory milestone for lifespan extension. The gray…

Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs designed to…

Pauling.AI’s Javier Tordable on why aging biology outpaces the business model and how AI can reset the cost curve. We…

Ahead Health lands $6m in seed funding to accelerate digital-first approach to early detection of disease. Swiss preventive health startup…

Phase 1b results for GT-02287 point to biological impact in Parkinson’s, strengthening the case for disease-modifying approaches. Progress in Parkinson’s…

NRG Therapeutics takes a first-in-human step toward disease-modifying treatments for ALS and Parkinson’s, targeting aging at cellular level. There are…